Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 341-357
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 16
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 30
Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 29
New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 14
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 14
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10
The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102075-102075
Closed Access | Times Cited: 21
Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated
G.D. Kim, Jiyoon Lee, Joohun Ha, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5082-5082
Open Access | Times Cited: 17
Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities
Prasanna Srinivasan Ramalingam, Sujatha Elangovan, M. Janaki Ramaiah, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Establishing a robust triangulation framework to explore the relationship between hearing loss and Parkinson’s disease
Hao Zhang, Keying Chen, Tongyu Gao, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Cell-penetrating proteins and peptides as a promising theragnostic agent for neurodegenerative disorder
Bhaskaranand Pancholi, Mayank Kumar Choudhary, Manoj Kumar, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106816-106816
Open Access
Suicidal Ideation After Subthalamic Stimulation in Parkinson’s Disease: A Critical Concern
Gideon S. Alex, Oluwatobiloba Israel Popoola, Inibehe Ime Okon
Brain and Spine (2025), pp. 104247-104247
Open Access
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Neuroprotective Effect Of Thymus Vulgaris On Paraquat Induced Parkinson’s Disease
Naheed Akhter, Iqra Rafiq, Amer Jamil, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151740-151740
Closed Access
Chenodeoxycholic Acid-Mediated neuroprotection via α-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson’s disease
Mehwish Mehreen, Megat Syahirul Amin Megat Ali, Hina Tariq, et al.
Neuroscience (2025)
Closed Access
The neuroprotective effect of vitamin D in Parkinson's disease: association or causation
Amin A. Hafiz
Nutritional Neuroscience (2023) Vol. 27, Iss. 8, pp. 870-886
Closed Access | Times Cited: 5
Dietary Phenolic Compounds Exert Some of Their Health-Promoting Bioactivities by Targeting Liver X Receptor (LXR) and Retinoid X Receptor (RXR)
J. Abraham Domínguez‐Ávila
Foods (2023) Vol. 12, Iss. 23, pp. 4205-4205
Open Access | Times Cited: 5
A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10198-10215
Closed Access | Times Cited: 1
Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Targeting the sphingolipid rheostat in IDH1mut glioma alters cholesterol homeostasis and triggers apoptosis via membrane degradation
Tyrone Dowdy, Helena Muley Vilamu, Adrian Lita, et al.
(2024)
Closed Access
SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease
Polina Petkova‐Kirova, Anastasia Kolchina, Stephan Baas, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Identification of Novel Compounds Targeting the Liver X Receptor (LXR): In-silico Studies, Screening, Molecular Docking, and Chemico-pharmacokinetic Analysis
Sarder Arifuzzaman, Zubair Khalid Labu, Md. Harun -Or- Rashid, et al.
Biomedical & Pharmacology Journal (2024) Vol. 17, Iss. 3, pp. 1499-1522
Open Access
Therapeutic potential of liver X receptor beta in depression and anxiety
Xiao-Yu Song, Jan-Åke Gustafsson
Brain medicine : (2024), pp. 1-4
Closed Access
Page 1 - Next Page

Scroll to top